Use of persistent infections with vaccinia virus recombinants to introduce alterations in foreign proteins: An application to HIV-1 env protein

Virus Research

Volumn 46, Issue 1-2, 1996, Pages 45-56

  Esteban, Mariano ^a   Rodríguez, Juan Ramón ^a   Jimenez, Victoria ^a   Rodríguez, Dolores ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

HIV env; persistent infections; vaccinia virus

Indexed keywords

ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOMA CELL LINE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, ENV; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MICE; RECOMBINATION, GENETIC; SERIAL PASSAGE; TUMOR CELLS, CULTURED; VACCINIA; VACCINIA VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0030580593     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(96)01380-9     Document Type: Article

References (28)

1. Chainer, I.R., Heurichwork, S., Hadida, F., Pelletier, E., Okseuhendler, E., Autran, B. and Wain-Hobson. (1994) HIV and T cell expression in splenic white pulps is accompanied by infiltration of HIV specific cytotoxic T lymphocytes. Cell. 78, 373-387.
2. Chakrabarti, L., Emerman, M., Tiollais, P. and Sonigo, P. (1989). The cytoplasmic domain of simian immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 63, 4395-4403.
3. Clerici, M. and Shearer, G.M. (1993). A Th1-Th2 switch in a critical step in the etiology of HIV infection. Immunol. Today. 14, 107-111.
4. Cohen, J.T. (1993). T cell shift: key to AIDS therapy?. Science. 262, 175-176.
5. Dallo, S. and Esteban, M. (1987). Isolation and characterization of attenuated mutants of vaccinia virus. Virology. 159, 408-422.
6. Fenner, F., Wittek, R. and Dumbell, K.R. (1989). The Orthopoxviruses. Academic Press, San Diego.
7. Hirsch, U.M., Edmonson, P., Muphey-Corb, M., Arbeille, B., Johnson, P.R. and Mullins, J.I. (1989). SIV adaptation to human cells. Nature 341, 573-574.
8. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
9. Kim, K.J., Kanellopoulos-Iangevin, C., Merwin, R.M., Sachs, D.H. and Asofsky, R. (1979). Establishment and characterization of Balb/c lymphoma lines with B cell properties. J. Immunol. 122, 549-554.
10. Levy, J.A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289.
11. Meyers, G., Wain-Hobson, S., Korber, B., Smith, R.F. and Paulakis, G.N. (1993). Human retroviruses and AIDS. A compilation and analyses of nucleic acid and amino acid sequences. Theoretical biology and byophysics group T-10. Los Alamos National Laboratory, Los Alamos, NM, USA.
12. Moore, J.P., Willey, R.L., Lewis, G.K., Robinson, J. and Sodroski, J. (1994) Immunological evidence for interactions between the first, second and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J. Virol. 68, 6836-6847.
13. Paez, E., Dallo, S. and Esteban, M. (1985), Generation of a dominant 8 MDa deletion at the left terminus of vaccinia virus DNA. Proc. Natl. Acad. Sci. USA. 82, 3365-3369.
14. Paez, E., Dallo, S. and Esteban, M. (1987). Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence. J. Virol. 61, 2642-2647.
15. Pogo, B.G. and Friend, D. (1982). Persistent infection of Friend erythroleukemia cells with vaccinia virus. Proc. Natl. Acad. Sci. USA. 79, 4805-4809.
16. Pogo, B.G., Lai, A.C., Joesten, M.E., Royston, M.E. and Holloway, D. (1991). Changes in cell gene expression in human leukemic cells persistently infected with vaccinia virus. Virus Res. 19, 131-138.
17. Ritter, G.D., Mulligan, M., Lydy, S.L. and Compans, R.W. (1993). Cell fusion activity of the simian immunodeficiency virus envelope protein is modified by the intracytoplasmic domain. Virology. 197, 255-264.
18. Rodríguez, D., Rodríguez, J-R., Rodriguez, J.F., Trauber, D. and Esteban, M. (1989). Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc. Natl. Acad. Sci. USA. 86, 1287-1291.
19. I- envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J. Virol. 61, 395-404.
20. Salk, J., Bretscher, P.A. and Salk, P.A. (1993). A strategy for prophylactic vaccination against HIV. Science. 260, 1270-1272.
21. Schawaller, M., Smith, G.E., Skehel, J.J. and Wiley, D.C. (1989). Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology. 172, 367-369.
22. Smith, G.L. (1993). Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol. 74, 1725-1740.
23. Stein, B.S. and Engleman, E.G. (1990). Intracellular processing of the gp160 HIV-1 envelope precursor. J. Biol. Chem. 265, 2640-2649.
24. Temin, H.O. (1993). Retrovirus variation and reverse transcription: abnormal strand transfers results in retrovirus genetic variation. Proc. Natl. Acad. Sci. USA. 90, 6900-6903.
25. Wei, Y., Ghosh, S.K., Taylor, M.E., Johnson, U.A., Emini, E.A., Deutsh, E.P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H., Saag, M.S. and Shaw, G.M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
26. Weiss, C.D., Levy, J.A. and White, J.M. (1990). Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1-particles. J. Virol. 64, 5674-5677.
27. Willey, R.L., Bonifacino, J.S., Potts, B.J., Martin, M.A. and Klansner, R.D. (1988). Biosynthesis, cleavage and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA. 85, 9580-9584.
28. Zaides, Y., Yagello, M., Veselovskaya, T., Schmitt, D., Rykova, L., Fenouillet, E. and Gluckman, J.C. (1994). Extensive C-terminal deletion in human immunodeficiency virus type 1 env glycoprotein arising after long-term culture of chronically infected cells. J. Gen. Virol. 75, 2963-2975.